FOR IMMEDIATE RELEASE
WASHINGTON (June 20, 2011) – LUNGevity Foundation announced that it is awarding $2 million to fund nine of the most promising lung cancer research proposals in the areas of early detection and targeted therapeutics. The Foundation has the largest grant awards program of any lung cancer organization in the United States.
Awards for early detection research were made to:
Awards for targeted therapeutics were made to:
“LUNGevity Foundation is truly encouraged by the breadth and quality of the research we have chosen to support,” said Andrea Stern Ferris, President of LUNGevity Foundation. “We received 67 grant applications and many of them were truly promising. We rigorously reviewed and rated each application and feel very good about the ones we have chosen to support. It would be wonderful if we collectively, as a nation, would find a way to support other deserving research projects. Lung cancer is our nation’s number-one cancer killer, taking nearly 160,000 lives each year. We desperately need to find a way to stop it from taking such a terrible toll on this country.”
Eighty-four percent of lung cancer patients die less than five years after their diagnosis, yet government and corporate funding largely overlook lung cancer research. LUNGevity works to make up for this disparity by allocating private donations to translational research that can lead to breakthroughs in diagnosing and treating lung cancer.
The Foundation employs its Scientific Advisory Board, 15 prominent and leading scientists and researchers, as well as additional experts to ensure that grants are awarded to the proposals with the greatest potential of saving lives. Under the guidance of the Advisory Board, chaired by Dr. Pierre Massion, MD, Associate Professor of Medicine and Cancer Biology in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center, LUNGevity has become the nation’s premier private grant-making organization funding research for the detection and treatment of lung cancer.
For additional information about the grants or to learn more about LUNGevity Foundation please visit www.lungevity.org. To arrange an interview with Andrea Ferris or an award recipient, please contact Victoria Shapiro at 202-414-0774 or email@example.com.
About LUNGevity Foundation
The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.
In order to accomplish its mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer. LUNGevity also supports the largest national grassroots lung cancer network.
LUNGevity seeks to inspire the nation to commit to ending lung cancer.
About Lung Cancer
# # #